The clinic of the liver

   The clinic of the liver (hepatitis), Located in Motahhary Clinic

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences

   This clinic begins operation since 1995-1996. Patients with hepatitis B and Care referred to thiscenter. These patients are referred from different centers especially Iranian Blood TransfusionOrganization, urban and rural health centers, laboratories, hospitals and private practice. This clinic work in two times, morning and afternoon, from Saturday to Sunday of each week.
   For each patient medical record will be createdat admission to the clinic. Patient’s information is recorded on the questionnaire. Then the patients are visited by physicians. Laboratory and other additional test are requested for patients. After preparing the answer of patients ' tests, they are under the supervision of Specialist Fellow of Gastroenterohepatology for follow up and treatment.After confirmation of hepatitis, one blood sample is taken from each patient and store in GEHRC lab for further research projects.
   Each patient, who needs treatment, is followed by related physician and patients who no need any treatment are checked routinely. After that, all patients’ information includes, history, therapy, laboratory data, and other medicinal information are recorded in hepatitis data bank. In this center other services such as consults about disease, route of infection, signs and how to prevent transmission to family are educated. In hepatitis B, the family of patient is screened and if is negative, is referred to the related center for charge free vaccination. From Saturday to Tuesday of each week, our consulters are ready for giving any advice for promote public awareness.
Call phone: 071-36474376; 071-36121104; 071-36121195
   In addition to the above mentioned works, patients with IBDs also register in this center. These patients are referred by Professor of Gastroenterohepatology and their information are record in specific data bank. Also, all executive activities related to the research projects or proposals for MD, Ph.D., residency, fellowship and etc. Overall, this center has two patients registery software:

    Hepatitis Registry
    IBD Registry

Clinic officials accountable: Zahra Mansoorabadi, Leila Kazemi, Leila Mansoorabadi

Clinic physician: Mrs. Dr. Lida Ahmadi

Hepatitis B is induced by hepatitis virus that invades to the hepatic cells. This disease is common in Asian countries and Iran is one of the high endemic regions. Hepatitis can destroy the hepatic cells and decreases liver functions.

How is HBV transmitted?
   HBV is transmitted through body fluids such as blood, mother’s milk and saliva (in some cases). Peoples with more chance of infection are Health center and laboratory staffs who deal with blood or other body fluids, childs with contact with patient, intravenous abusers and their friend who contact with needles, and peoples who have uncontrolled sexual activity. Because of Iran is one of the high endemic areas in the world, it is possible that your child contact with one HBV patient, so your child is at risk.


   Primary infection may induce no clear signs and symptoms and patient shows fatigue, decreased appetite and or mild fever. However, special sign of disease, Jaundice (which demonstrated clearly in the sclera), occasionally occur.

How to prevent?
   Vaccination: The best protective way is vaccination. Vaccine against this disease, which is administered in three subcutaneous injections in six months interval, can produce 90-95% immunoprotection. At the end of the injections period, a blood test must be performed to ensure from inducing antibody against disease. Previous studies demonstrate that in 5-10% cases which proper immunization is not produced, vaccination period can be repeated intramuscularly with well results. Peoples which vaccinated must be tested periodically to confirm that appropriate level of antibody against infection is existed.

After contact with patient or virus

   If person who is not vaccinated yet is deals with virus, immunoglubolin    can be administered in 1st 24 h or at least in one week after contact and this may prevent from infection (not completely). This drug must be repeated after 28-30 days and then the levels of antibody in the serum must be checked.       

Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran